Proteasome inhibitors in acute leukemia

Author： Niewerth Denise   Dingjan Ilse   Cloos Jacqueline   Jansen Gerrit   Kaspers Gertjan  

Publisher： Informa Healthcare

ISSN： 1473-7140

Source： Expert Review of Anticancer Therapy, Vol.13, Iss.3, 2013-03, pp. : 327-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines

By Liesveld Jane L.   Rosell Karen E.   Bechelli Jeremy   Lu Chaohui   Messina Patti   Mulford Deborah   Ifthikharuddin J. J.   Jordan Craig T.   Phillips II Gordon L.  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 439-450

Informa Healthcare

Access to resources Recommend Favorite

Proteasome inhibitors in the treatment of multiple myeloma

By McBride Ali   Ryan Patricia Y  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 339-358

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibitors Therapeutic Strategies for Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 8, 2009-10 ,pp. : 853-863

Bentham Science Publishers

Access to resources Recommend Favorite

The Ultrastructure of Hybrid Acute Leukemia: A Study of 15 Cases

By Ru Yong-xin   Wang Hui-jun   Yang Bing-xin   Liu Jin-hua   Li Zhan-qi   Li Cheng-wen   Wang Jian-xiang   Mi Ying-chang  

Ultrastructural Pathology, Vol. 29, Iss. 5, 2005-09 ,pp. : 341-347

Informa Healthcare

Access to resources Recommend Favorite